Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

Cited In for PubMed (Select 14645590)

1.

Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques.

Carnathan DG, Wetzel KS, Yu J, Lee ST, Johnson BA, Paiardini M, Yan J, Morrow MP, Sardesai NY, Weiner DB, Ertl HC, Silvestri G.

Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):518-23. doi: 10.1073/pnas.1407466112. Epub 2014 Dec 30.

2.

Epithelial stem cells as mucosal antigen-delivering cells: A novel AIDS vaccine approach.

White R, Chenciner N, Bonello G, Salas M, Blancou P, Gauduin MC.

Vaccine. 2013 Nov 25. pii: S0264-410X(13)01233-4. doi: 10.1016/j.vaccine.2013.09.006. [Epub ahead of print]

3.

Immunological and virological analyses of rhesus macaques immunized with chimpanzee adenoviruses expressing the simian immunodeficiency virus Gag/Tat fusion protein and challenged intrarectally with repeated low doses of SIVmac.

Cervasi B, Carnathan DG, Sheehan KM, Micci L, Paiardini M, Kurupati R, Tuyishime S, Zhou XY, Else JG, Ratcliffe SJ, Ertl HC, Silvestri G.

J Virol. 2013 Sep;87(17):9420-30. doi: 10.1128/JVI.01456-13. Epub 2013 Jun 26.

4.

Crosstalk between adaptive and innate immune cells leads to high quality immune protection at the mucosal borders.

Cheroutre H, Huang Y.

Adv Exp Med Biol. 2013;785:43-7. doi: 10.1007/978-1-4614-6217-0_5. Review.

5.

Elicitation of both anti HIV-1 Env humoral and cellular immunities by replicating vaccinia prime Sendai virus boost regimen and boosting by CD40Lm.

Zhang X, Sobue T, Isshiki M, Makino S, Inoue M, Kato K, Shioda T, Ohashi T, Sato H, Komano J, Hanabusa H, Shida H.

PLoS One. 2012;7(12):e51633. doi: 10.1371/journal.pone.0051633. Epub 2012 Dec 7.

6.
7.

Induction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinants.

Gu R, Stagnar C, Zaichenko L, Ramsingh AI.

Vaccine. 2012 May 21;30(24):3666-74. doi: 10.1016/j.vaccine.2012.03.034. Epub 2012 Mar 29.

8.

Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques.

Fuller DH, Rajakumar P, Che JW, Narendran A, Nyaundi J, Michael H, Yager EJ, Stagnar C, Wahlberg B, Taber R, Haynes JR, Cook FC, Ertl P, Tite J, Amedee AM, Murphey-Corb M.

PLoS One. 2012;7(3):e33715. doi: 10.1371/journal.pone.0033715. Epub 2012 Mar 19.

9.

Co-immunization with multimeric scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells.

Jaworski JP, Krebs SJ, Trovato M, Kovarik DN, Brower Z, Sutton WF, Waagmeester G, Sartorius R, D'Apice L, Caivano A, Doria-Rose NA, Malherbe D, Montefiori DC, Barnett S, De Berardinis P, Haigwood NL.

PLoS One. 2012;7(2):e31464. doi: 10.1371/journal.pone.0031464. Epub 2012 Feb 16.

10.

The development of an AIDS mucosal vaccine.

Tang X, Chen Z.

Viruses. 2010 Jan;2(1):283-97. doi: 10.3390/v2010283. Epub 2010 Jan 22.

11.

Pyrosequencing reveals restricted patterns of CD8+ T cell escape-associated compensatory mutations in simian immunodeficiency virus.

Burwitz BJ, Sacha JB, Reed JS, Newman LP, Norante FA, Bimber BN, Wilson NA, Watkins DI, O'Connor DH.

J Virol. 2011 Dec;85(24):13088-96. doi: 10.1128/JVI.05650-11. Epub 2011 Oct 12.

12.

Mucosal memory CD8⁺ T cells are selected in the periphery by an MHC class I molecule.

Huang Y, Park Y, Wang-Zhu Y, Larange A, Arens R, Bernardo I, Olivares-Villagómez D, Herndler-Brandstetter D, Abraham N, Grubeck-Loebenstein B, Schoenberger SP, Van Kaer L, Kronenberg M, Teitell MA, Cheroutre H.

Nat Immunol. 2011 Oct 2;12(11):1086-95. doi: 10.1038/ni.2106.

13.

GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivo.

Vojnov L, Martins MA, Almeida JR, Ende Z, Rakasz EG, Reynolds MR, Leon EJ, Weisgrau KL, Burwitz BJ, Folkvord JM, de Santana MG, Neves PC, Connick E, Skinner PJ, Gostick E, O'Connor DH, Wilson NA, Bonaldo MC, Galler R, Price DA, Douek DC, Watkins DI.

PLoS One. 2011;6(8):e23515. doi: 10.1371/journal.pone.0023515. Epub 2011 Aug 26.

14.

Reduction of CD4+ T cells in vivo does not affect virus load in macaque elite controllers.

Mudd PA, Ericsen AJ, Price AA, Wilson NA, Reimann KA, Watkins DI.

J Virol. 2011 Jul;85(14):7454-9. doi: 10.1128/JVI.00738-11. Epub 2011 May 18.

15.

Simian immunodeficiency virus SIVmac239Deltanef vaccination elicits different Tat28-35SL8-specific CD8+ T-cell clonotypes compared to a DNA prime/adenovirus type 5 boost regimen in rhesus macaques.

Burwitz BJ, Ende Z, Sudolcan B, Reynolds MR, Greene JM, Bimber BN, Almeida JR, Kurniawan M, Venturi V, Gostick E, Wiseman RW, Douek DC, Price DA, O'Connor DH.

J Virol. 2011 Apr;85(7):3683-9. doi: 10.1128/JVI.02112-10. Epub 2011 Jan 26.

16.

Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challenge.

Alpert MD, Rahmberg AR, Neidermyer W, Ng SK, Carville A, Camp JV, Wilson RL, Piatak M Jr, Mansfield KG, Li W, Miller CJ, Lifson JD, Kozlowski PA, Evans DT.

J Virol. 2010 Oct;84(20):10748-64. doi: 10.1128/JVI.00945-10. Epub 2010 Aug 11.

18.

Is an HIV vaccine possible?

Wilson NA, Watkins DI.

Braz J Infect Dis. 2009 Aug;13(4):304-10. Review.

19.

Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques.

Bonaldo MC, Martins MA, Rudersdorf R, Mudd PA, Sacha JB, Piaskowski SM, Costa Neves PC, Veloso de Santana MG, Vojnov L, Capuano S 3rd, Rakasz EG, Wilson NA, Fulkerson J, Sadoff JC, Watkins DI, Galler R.

J Virol. 2010 Apr;84(7):3699-706. doi: 10.1128/JVI.02255-09. Epub 2010 Jan 20.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk